Any history or presence of poorly controlled gastrointestinal disorders that could affect the absorption of the study drug (e.g. Crohns disease, ulcerative colitis, chronic diarrhea, malabsorption)
Any history or presence of poorly controlled gastrointestinal disorders that could affect the absorption of the study drug (e.g. Crohns disease, ulcerative colitis, chronic diarrhea, malabsorption)
Any history or presence of poorly controlled gastrointestinal disorders that could affect the absorption of the study drug (e.g. Crohns disease, ulcerative colitis, chronic diarrhea, malabsorption)
Inability to swallow oral medication; or the presence of a poorly controlled gastrointestinal disorder that could significantly affect the absorption of oral study drug  e.g. Crohns disease, ulcerative colitis, chronic diarrhea (defined as >  loose stools per day), malabsorption, or bowel obstruction.
Patient is unable to take drugs orally due to disorders or diseases that may affect gastrointestinal function, such as inflammatory bowel diseases (eg, Crohns disease, ulcerative colitis) or malabsorption syndrome, or procedures that may affect gastrointestinal function, such as gastrectomy, enterectomy, or colectomy
Any history or presence of poorly controlled gastrointestinal disorders that could affect the absorption of the study drug (e.g. Crohns disease, ulcerative colitis, chronic diarrhea, malabsorption)
The presence of poorly controlled gastrointestinal disorders that could affect the absorption of the afatinib (e.g. Crohns disease, ulcerative colitis, chronic diarrhea, malabsorption)
History of poorly controlled gastrointestinal disorders that could affect the absorption of the study drug (for example, Crohns disease, ulcerative colitis); patients requiring feeding tubes are permitted
History of poorly controlled gastrointestinal disorders that could affect the absorption of the study drug (eg, Crohns disease, ulcerative colitis); patients requiring feeding tubes are permitted
Any history or presence of poorly controlled gastrointestinal disorders that could affect the absorption of the study drug
